<DOC>
	<DOCNO>NCT01290536</DOCNO>
	<brief_summary>This prospective pilot study design document safety efficacy liver-directed therapy colorectal , neuroendocrine , cholangiocarcinoma , melanoma , breast cancer metastases liver use Yttrium-90 glass microspheres ( TheraSphere ) .</brief_summary>
	<brief_title>Yttrium-90 Radioembolization Using Glass Microspheres ( TheraSphere ) Patients With Liver Metastases</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Diagnosis metastatic colorectal , neuroendocrine , cholangiocarcinoma , melanoma , breast malignancy liver dominant disease . Diagnosis may make histo cytopathology , clinical imaging criterion . The cancer unresectable . All patient must chemotherapeutic regimen 30 day prior 30 day TheraSphere treatment . Concurrent therapy octreotide permit , appropriate . Eastern Cooperative Oncology Group ( ECOG ) performance status 02 . Age 18 year old . Able understand inform consent . Evidence potential delivery great 16.5 mCi ( 30 Gy absorb dose ) radiation lung either : single TheraSphere administration ; cumulative delivery radiation lung great 50 Gy multiple treatment . Evidence detectable Tc99m macroaggregated albumin deposition stomach duodenum , application establish angiographic technique stop deposition . Previous radiation therapy lung and/or upper abdomen Pregnancy Symptomatic lung disease . Significant extrahepatic disease represent imminent lifethreatening outcome . Active uncontrolled infection Any pretreatment laboratory finding within 30 day treatment demonstrating : Aspartate alanine aminotransferase level great 5 time upper normal limit . Serum bilirubin great 2 mg/dl Infiltrative tumor image Tumor volume great 70 % liver volume Tumor volume great 50 % liver volume serum albumin level le 3 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Liver metastasis</keyword>
</DOC>